The fight against leprosy is one of the greatest public health successes in history.Yet，still today，2to3million people are living with physical disability and stigma as a result of the disease。
预应力钢筋30years，Novartis has been working with partners around the world toeliminate leprosy.Multidrug therapy（MDT）has been a major breakthrough in the treatment of leprosy and its free availability has reduced the global disease burden by95%in the past three decades。
Since2000，Novartis has donated more than70 million blister packs of multidrug therapy（MDT）valued at approximately USD124 million through the World Health Organization（WHO），helping to treat more than7.5 million leprosy patients worldwide.Further，the donation has made it possible to interrupt the transmission of leprosy and prevent disabilities。
上下连接线
Since2000，Novartis has been donating MDT through the WHO.In2021，we renewed our pledge to extend our donation with the WHO through地下five-year agement.
In2019，theNovartis Foundation announced a strategic alliance with Microsoft and the Oswaldo Cruz Foundationto explore the development of an AI-enabled accelerator of leprosy screening/dagnosis that analyzes images of skin lesions。
互通列车两用配电装置
Launched in 2014，theLeprosy Post-Posure Prophylaxis（LPEP）1个program has tested the real-world effectiveness of providing preventative treatment to close contacts of newly diagnosed leprosy patients.The evidence generated by LPEP in the seven countries where the program is operational led to the inclusion of this strategy in theWHO Guidelines for the Diagnosis，Treatment and Prevention of Leprosyin2018。Results from the program，which covered more than150000people across seven countries，showed that large-scale implementation of this strategy could accelerate leprosy elimination。
Read More
合作用电灯泡
